Unknown PHASE1 INTERVENTIONAL 1-arm NCT02277158

Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

A Phase I Study of Concurrent Radiotherapy and Tegafur, Gimeracil and Oteracil Potassium Capsule(S-1) as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Conditions Rectal Cancer

Interventions Chemoradiotherapy

Updated 5 times since 2017 Last updated: Nov 30, 2014 Started: Nov 30, 2014 Primary completion: Jun 30, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02277158, this PHASE1 trial focuses on Rectal Cancer and remains ongoing. Sponsored by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, it has been updated 5 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Data source: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China